|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics. CA Cancer J Clin. 59:225–249. 2009.
|
|
2
|
Kris MG, Natale RB, Herbst RS, Lynch TJ
Jr, Prager D, Belani CP, Schiller JH, Kelly K, Spiridonidis H,
Sandler A, Albain KS, Cella D, Wolf MK, Averbuch SD, Ochs JJ and
Kay AC: Efficacy of gefitinib, an inhibitor of the epidermal growth
factor receptor tyrosine kinase, in symptomatic patients with
non-small cell lung cancer: A randomized trial. JAMA.
290:2149–2158. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fukuoka M, Yano S, Giaccone G, Tamura T,
Nakagawa K, Douillard JY, Nishiwaki Y, Vansteenkiste J, Kudoh S,
Rischin D, Eek R, Horai T, Noda K, Takata I, Smit E, Averbuch S,
Macleod A, Feyereislova A, Dong RP and Baselga J:
Multi-institutional randomized phase II trial of gefitinib for
previously treated patients with advanced nonsmall-cell lung cancer
(The IDEAL 1 Trial). J Clin Oncol. 21:2237–2246. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharma SV, Bell DW, Settleman J and Haber
DA: Epidermal growth factor receptor mutations in lung cancer. Nat
Rev Cancer. 7:169–181. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lynch TJ, Bell DW, Sordella R,
Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat
SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J and
Haber DA: Activating mutations in the epidermal growth factor
receptor underlying responsiveness of non-small-cell lung cancer to
gefitinib. N Engl J Med. 350:2129–2139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Paez JG, Jänne PA, Lee JC, Tracy S,
Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ,
Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE and
Meyerson M: EGFR mutations in lung cancer: Correlation with
clinical response to gefitinib therapy. Science. 304:1497–1500.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yatabe Y and Mitsudomi T: Epidermal growth
factor receptor mutations in lung cancers. Pathol Int. 57:233–244.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gu D, Scaringe WA, Li K, Saldivar JS, Hill
KA, Chen Z, Gonzalez KD and Sommer SS: Database of somatic
mutations in EGFR with analyses revealing indel hotspots but no
smoking-associated signature. Hum Mutat. 28:760–770. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu JY, Wu SG, Yang CH, Gow CH, Chang YL,
Yu CJ, Shih JY and Yang PC: Lung cancer with epidermal growth
factor receptor exon 20 mutations is associated with poor gefitinib
treatment response. Clin Cancer Res. 14:4877–4882. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sequist LV, Joshi VA, Jänne PA, Muzikansky
A, Fidias P, Meyerson M, Haber DA, Kucherlapati R, Johnson BE and
Lynch TJ: Response to Treatment and Survival of patients with
Non-Small Cell Lung Cancer Undergoing Somatic EGFR Mutation
Testing. Oncologist. 12:90–98. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Arnold K, Bordoli L, Kopp J and Schwede T:
The SWISS-MODEL Workspace: A web-based environment for protein
structure homology modelling. Bioinformatics. 22:195–201. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Engelman JA and Janne PA: Mechanisms of
acquired resistance to epidermal growth factor receptor tyrosine
kinase inhibitors in non-small cell lung cancer. Clin Cancer Res.
14:2895–2899. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bean J, Brennan C, Shih JY, Riely G, Viale
A, Wang L, Chitale D, Motoi N, Szoke J, Broderick S, Balak M, Chang
WC, Yu CJ, Gazdar A, Pass H, Rusch V, Gerald W, Huang SF, Yang PC,
Miller V, Ladanyi M, Yang CH and Pao W: MET amplification occurs
with or without T790M mutations in EGFR mutant lung tumors with
acquired resistance to gefitinib or erlotinib. Proc Natl Acad Sci
USA. 104:20932–20937. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yun CH, Mengwasser KE, Toms AV, Woo MS,
Greulich H, Wong KK, Meyerson M and Eck MJ: The T790M mutation in
EGFR kinase causes drug resistance by increasing the affinity for
ATP. Proc Natl Acad Sci USA. 105:2070–2075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maheswaran S, Sequist LV, Nagrath S, Ulkus
L, Brannigan B, Collura CV, Inserra E, Diederichs S, Iafrate AJ,
Bell DW, Digumarthy S, Muzikansky A, Irimia D, Settleman J,
Tompkins RG, Lynch TJ, Toner M and Haber DA: Detection of mutations
in EGFR in circulating lung-cancer cells. N Engl J Med.
359:366–377. 2008. View Article : Google Scholar : PubMed/NCBI
|
